321 related articles for article (PubMed ID: 25952784)
41. Latest progress in molecular biology and treatment in genitourinary tumours.
González-Del-Alba A; Arranz JÁ; Bellmunt J; Maroto JP; Fernández-Calvo O; Valderrama BP; González-Billalabeitia E; Méndez-Vidal MJ; Cassinello J; Romero-Laorden N; Climent MÁ; Puente J; Peláez I; Lázaro-Quintela M; Gallardo E; Suárez C
Clin Transl Oncol; 2020 Dec; 22(12):2175-2195. PubMed ID: 32440915
[TBL] [Abstract][Full Text] [Related]
42. The emerging clinical relevance of genomics in cancer medicine.
Berger MF; Mardis ER
Nat Rev Clin Oncol; 2018 Jun; 15(6):353-365. PubMed ID: 29599476
[TBL] [Abstract][Full Text] [Related]
43. Pediatric genitourinary tumors.
Agarwal SK; Prowse OA; Merguerian PA
Curr Opin Oncol; 1997 May; 9(3):307-12. PubMed ID: 9229155
[TBL] [Abstract][Full Text] [Related]
44. Clinical applications of artificial intelligence in urologic oncology.
Hosein S; Reitblat CR; Cone EB; Trinh QD
Curr Opin Urol; 2020 Nov; 30(6):748-753. PubMed ID: 32941255
[TBL] [Abstract][Full Text] [Related]
45. What have we learned from exceptional tumour responses?: Review and perspectives.
Mehra N; Lorente D; de Bono JS
Curr Opin Oncol; 2015 May; 27(3):267-75. PubMed ID: 25811347
[TBL] [Abstract][Full Text] [Related]
46. Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology.
Pasipoularides A
Int J Cardiol; 2017 Mar; 230():384-401. PubMed ID: 28057368
[TBL] [Abstract][Full Text] [Related]
47. Gene and immune-based therapies for genitourinary malignancies: current status and future prospects.
Zisman A; Pantuck AJ; Belldegrun A
Isr Med Assoc J; 2000 Jan; 2(1):33-42. PubMed ID: 10892369
[No Abstract] [Full Text] [Related]
48. Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin.
Millis SZ; Bryant D; Basu G; Bender R; Vranic S; Gatalica Z; Vogelzang NJ
Clin Genitourin Cancer; 2015 Feb; 13(1):e37-49. PubMed ID: 25178641
[TBL] [Abstract][Full Text] [Related]
49. Personalized oncology: genomic screening in phase 1.
Tuxen IV; Jønson L; Santoni-Rugiu E; Hasselby JP; Nielsen FC; Lassen U
APMIS; 2014 Aug; 122(8):723-33. PubMed ID: 25046202
[TBL] [Abstract][Full Text] [Related]
50. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care.
Bex A; Gore M; Mulders P; Sternberg CN
BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610
[TBL] [Abstract][Full Text] [Related]
51. Emerging therapeutic agents for genitourinary cancers.
Zarrabi K; Paroya A; Wu S
J Hematol Oncol; 2019 Sep; 12(1):89. PubMed ID: 31484560
[TBL] [Abstract][Full Text] [Related]
52. [Precision medicine in oncology].
Mack E
Inn Med (Heidelb); 2024 Mar; 65(3):194-201. PubMed ID: 37921995
[TBL] [Abstract][Full Text] [Related]
53. Toward a More Precise Future for Oncology.
Murciano-Goroff YR; Taylor BS; Hyman DM; Schram AM
Cancer Cell; 2020 Apr; 37(4):431-442. PubMed ID: 32289268
[TBL] [Abstract][Full Text] [Related]
54. Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer.
Jones RT; Felsenstein KM; Theodorescu D
Urol Clin North Am; 2016 Feb; 43(1):77-86. PubMed ID: 26614030
[TBL] [Abstract][Full Text] [Related]
55. The folate receptor as a rational therapeutic target for personalized cancer treatment.
Assaraf YG; Leamon CP; Reddy JA
Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
[TBL] [Abstract][Full Text] [Related]
56. Follow-up surveillance strategies for genitourinary malignancies.
Evans CP
Cancer; 2002 Jun; 94(11):2892-905. PubMed ID: 12115377
[TBL] [Abstract][Full Text] [Related]
57. [Oncogenes and oncogene products in urogenital cancer cells].
Deguchi N; Tachibana M; Tazaki H
Hum Cell; 1988 Mar; 1(1):20-4. PubMed ID: 2978981
[TBL] [Abstract][Full Text] [Related]
58. [New directions in biomarker research, drug development and personalized medicine].
Németh G; Jelinek I
Magy Onkol; 2013 Mar; 57(1):5-10. PubMed ID: 23573515
[TBL] [Abstract][Full Text] [Related]
59. Towards defining biomarkers indicating resistances to targeted therapies.
Stehle F; Schulz K; Seliger B
Biochim Biophys Acta; 2014 May; 1844(5):909-16. PubMed ID: 24269379
[TBL] [Abstract][Full Text] [Related]
60. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project.
Niklinski J; Kretowski A; Moniuszko M; Reszec J; Michalska-Falkowska A; Niemira M; Ciborowski M; Charkiewicz R; Jurgilewicz D; Kozlowski M; Ramlau R; Piwkowski C; Kwasniewski M; Kaczmarek M; Ciereszko A; Wasniewski T; Mroz R; Naumnik W; Sierko E; Paczkowska M; Kisluk J; Sulewska A; Cybulski A; Mariak Z; Kedra B; Szamatowicz J; Kurzawa P; Minarowski L; Charkiewicz AE; Mroczko B; Malyszko J; Manegold C; Pilz L; Allgayer H; Abba ML; Juhl H; Koch F;
Adv Med Sci; 2017 Sep; 62(2):405-413. PubMed ID: 28646744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
